Read + Share
Fleisher AS, Munsie LM, Perahia DGS, Andersen SW, et al. Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a
Phase 2 Study in Early Symptomatic Alzheimer Disease. Neurology 2024;102:e208061.
PMID: 38386949
|
 |
|
Fleisher AS, Munsie LM, Perahia DGS, Andersen SW, et al. Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a
Phase 2 Study in Early Symptomatic Alzheimer Disease. Neurology 2024;102:e208061.
PMID: 38386949
|
|
|
|